Evidence map›Paper›PMID 28808002›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Optimized strategy for in vivo Cas9-activation in

Ben Ewen-Campen, Donghui Yang-Zhou, Vitória R Fernandes, Delfina P González, Lu-Ping Liu, Rong Tao, Xingjie Ren, Jin Sun, Yanhui Hu, Jonathan Zirin and 3 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Review
  2. Embedded CRISPRi Enhances Gene-Silencing Efficiency in Drosophila.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. RNA-RNA interactions coordinate GABA metabolism and signaling.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. HyperCas12a enables multiplexed CRISPRi screens.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Review
  12. On RNA-programmable gene modulation as a versatile set of principles targeting muscular dystrophies.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Review
  13. eLife · 2024
    Article
  14. Article
  15. Review
  16. A drug stabilizable GAL80Scientific reports · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ben Ewen-CampenDepartment of Genetics, Harvard Medical School, Boston, MA 02115.
Donghui Yang-ZhouDepartment of Genetics, Harvard Medical School, Boston, MA 02115.
Vitória R FernandesDepartment of Genetics, Harvard Medical School, Boston, MA 02115.
Delfina P GonzálezDepartment of Genetics, Harvard Medical School, Boston, MA 02115.
Lu-Ping LiuDepartment of Genetics, Harvard Medical School, Boston, MA 02115.
Rong TaoDepartment of Genetics, Harvard Medical School, Boston, MA 02115.
Xingjie RenGene Regulatory Laboratory, School of Medicine, Tsinghua University, Beijing 100084, China.
Jin SunGene Regulatory Laboratory, School of Medicine, Tsinghua University, Beijing 100084, China.
Yanhui HuDepartment of Genetics, Harvard Medical School, Boston, MA 02115.
Jonathan ZirinDepartment of Genetics, Harvard Medical School, Boston, MA 02115.
Stephanie E MohrDepartment of Genetics, Harvard Medical School, Boston, MA 02115.
Jian-Quan NiGene Regulatory Laboratory, School of Medicine, Tsinghua University, Beijing 100084, China nijq@mail.tsinghua.edu.cn perrimon@receptor.med.harvard.edu.
Norbert PerrimonDepartment of Genetics, Harvard Medical School, Boston, MA 02115; nijq@mail.tsinghua.edu.cn perrimon@receptor.med.harvard.edu.

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI A. Heather Eliassen · 1985 to 2026
$330.6M
New collections of dsRNAs and overexpression miRNA constructs to supplement RNAiR01GM067761 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI PERRIMON, NORBERT · 2003 to 2019
$15.5M
Drosophila Transgenic RNAi Resource ProjectR01GM084947 · NIGMS · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2008 to 2019
$9.8M
Drosophila resources for modeling human diseasesR24OD021997 · OD · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2016 to 2019
$1.5M
Functional analysis of systemic factors regulating germline stem cellsF32GM113395 · NIGMS · HARVARD MEDICAL SCHOOL · PI EWEN-CAMPEN, BENJAMIN SCOTT · 2015 to 2017
$162k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA006516NIGMS NIH HHS F32 GM113395NIGMS NIH HHS R01 GM067761NIGMS NIH HHS R01 GM084947NIH HHS R24 OD021997
6 · The paper itself

Abstract

While several large-scale resources are available for in vivo loss-of-function studies in

Indexed as

CRISPR-Cas SystemsAnimalsDrosophila melanogasterDrosophila ProteinsGene Expression Regulation, DevelopmentalGenomeGenotypeLarvaRNATranscriptional ActivationTranscription FactorsDrosophila ProteinsRNATranscription FactorsCas9-activatorsCRISPRaCRISPR/Cas9CRISPR mutagenesisgain-of-function

Identifiers

PMID28808002
PMCPMC5584449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.